Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. [electronic resource] by
- Van Valckenborgh, E
- De Raeve, H
- Devy, L
- Blacher, S
- Munaut, C
- Noël, A
- Van Marck, E
- Van Riet, I
- Van Camp, B
- Vanderkerken, K
Producer: 20020402
In:
British journal of cancer vol. 86
Availability: No items available.
|
|
|
8.
|
Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies. [electronic resource] by
- Lemaire, M
- D'Huyvetter, M
- Lahoutte, T
- Van Valckenborgh, E
- Menu, E
- De Bruyne, E
- Kronenberger, P
- Wernery, U
- Muyldermans, S
- Devoogdt, N
- Vanderkerken, K
Producer: 20140408
In:
Leukemia vol. 28
Availability: No items available.
|
|
|
9.
|
|
|
|
10.
|
Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. [electronic resource] by
- Caers, J
- Deleu, S
- Belaid, Z
- De Raeve, H
- Van Valckenborgh, E
- De Bruyne, E
- Defresne, M-P
- Van Riet, I
- Van Camp, B
- Vanderkerken, K
Producer: 20070831
In:
Leukemia vol. 21
Availability: No items available.
|
|
|
11.
|
The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models. [electronic resource] by
- Deleu, S
- Lemaire, M
- Arts, J
- Menu, E
- Van Valckenborgh, E
- King, P
- Vande Broek, I
- De Raeve, H
- Van Camp, B
- Croucher, P
- Vanderkerken, K
Producer: 20091105
In:
Leukemia vol. 23
Availability: No items available.
|
|
|
12.
|
Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model. [electronic resource] by
- Van Valckenborgh, E
- Matsui, W
- Agarwal, P
- Lub, S
- Dehui, X
- De Bruyne, E
- Menu, E
- Empsen, C
- van Grunsven, L
- Agarwal, J
- Wang, Q
- Jernberg-Wiklund, H
- Vanderkerken, K
Producer: 20120807
In:
Leukemia vol. 26
Availability: No items available.
|